• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Organon & Co (OGN)

Ordinary Shares
Sell: $9.01|Buy: $9.24|Change: 0.22 (-2.38%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Address




Website

https://www.organon.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Organon & Co Second Quarter Earnings Conference Call for 20262026-08-05T08:30:00
Organon & Co Second Quarter Earnings Results for 20262026-08-05T00:00:00
Organon & Co Annual General Meeting for 20262026-06-10T09:00:00
Organon & Co First Quarter Earnings Conference Call for 20262026-05-01T08:30:00
Organon & Co First Quarter Earnings Results for 20262026-05-01T00:00:00
Organon & Co Annual Report for 20252026-02-27T00:00:00
Organon & Co Fourth Quarter Earnings Conference Call for 20252026-02-13T08:30:00
Organon & Co Fourth Quarter Earnings Results for 20252026-02-13T00:00:00
Organon & Co Third Quarter Earnings Conference Call for 20252025-10-31T08:30:00
Organon & Co Third Quarter Earnings Results for 20252025-10-31T00:00:00

Previous key dates

NameKey Date
Organon & Co Third Quarter Earnings Conference Call for 20252025-10-31T08:30:00
Organon & Co Third Quarter Earnings Results for 20252025-10-31T00:00:00
Organon & Co Second Quarter Earnings Conference Call for 20252025-08-05T08:30:00
Organon & Co Second Quarter Earnings Results for 20252025-08-05T00:00:00
Organon & Co Annual General Meeting for 20252025-06-10T09:00:00
Organon & Co First Quarter Earnings Conference Call for 20252025-05-01T08:30:00
Organon & Co First Quarter Earnings Result for 20252025-05-01T00:00:00
Organon & Co Annual Report for 20242025-02-28T00:00:00
Organon & Co Fourth Quarter Earnings Conference Call for 20242025-02-13T08:30:00
Organon & Co Fourth Quarter Earnings Result for 20242025-02-13T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-13T15:45:00
Organon & Co Third Quarter Earnings Conference Call for 20242024-10-31T08:30:00
Organon & Co Third Quarter Earnings Result for 20242024-10-31T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.